NCT00228267View on ClinicalTrials.gov

Propofol Injection for Daily Headache

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2007

Conditions
Chronic HeadacheAnalgesic Rebound HeadacheChronic Daily HeadacheHeadache, Intractable
Interventions
DRUG

Propofol

Trial Locations (1)

T6G 2B7

Multidisciplinary Pain Centre, Univ. Alta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT00228267 - Propofol Injection for Daily Headache | Biotech Hunter | Biotech Hunter